Efficacy of Modified Robert Jones Bandages on Reducing Invisible Blood Loss After Total Knee Arthroplasty
1 other identifier
interventional
80
1 country
1
Brief Summary
Total knee arthroplasty (TKA) is one of the most successful procedures in orthopaedic surgery. Nevertheless, significant postoperative blood loss and requirement of blood transfusion are still problematic. Total blood loss in TKA can be divided into visible and invisible blood loss. Visible blood loss (VBL) means blood loss from the surgical field and wound drainage while invisible blood loss (IBL) means residual blood in the knee, extravasation into the tissues and loss due to haemolysis. In usual practice, TKA is performed with a bloodless field using a tourniquet. Thus intraoperative blood loss can be negligible and postoperative drainage is only considered as VBLvisible. In terms of IBL, Sehat et al. found that TKA carried a substantial IBL. Their results shown the mean IBL was 765 ml or 49% of the mean total blood loss after TKA. Therefore, the true total blood loss was underestimated if not takes IBL into account. Modified Robert Jones bandage (MRJB) is a bulky compressive dressing that often used in orthopaedic practice. Various techniques of application have been proposed. From the previous study, MRJB could make and maintain the anterolateral muscle compartment pressure for at least 24 hours after TKA. Therefore, theoretically, this bandage can cause the tamponade effect that helps to reduce tissue edema and postoperative bleeding especially IBL after TKA. However this potential benefit of MRJB is unclear and the use of this bandage after TKA is still controversy in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2016
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedFirst Posted
Study publicly available on registry
March 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedMay 29, 2018
May 1, 2018
1.3 years
February 28, 2016
May 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Invisible blood loss after surgery
48 hours after surgery
Time (seconds) taken to perform time up and go test
meters, turn, walk back to the chair, then sit down.
6 weeks after surgery
Secondary Outcomes (5)
Postoperative visual analog pain score
48 hours after surgery
Circumferences of thigh
48 hours after surgery
Circumferences of knee
48 hours after surgery
Score from Oxford knee score questionnaire
6 weeks after surgery
Complication
6 weeks after surgery
Study Arms (2)
Modified Robert Jones bandage
EXPERIMENTALModified Robert Jones bandage is defined as a three-layers of thick cotton wool and two-layers of elastic bandages. The wool layers are put on firmly and overlapped the previous one by half at each turn. The elastic layers were pulled snugly with more tension distally than proximally. Before wrapping in each turn, the elastic bandage was stretched approximately 2 and 1.5 inches at below and above tibial tuberosity level, respectively. The whole bandage attains a thickness of about two inches and extends above the ankle joint to six inches above the knee joint. Before applying this bandage, the sterile gauze pads were placed over the wound and followed by WebrilTM padding (Covidien, Mansfield, MA, US).
Non compressive dressing
PLACEBO COMPARATORNon-compressive dressing is made by placing the sterile gauze pads over the wound and covering with the hypoallergenic self-adhesive, non-woven fabric tape.
Interventions
Modified Robert Jones bandage is defined as a three-layers of thick cotton wool and two-layers of elastic bandages. The wool layers are put on firmly and overlapped the previous one by half at each turn. The elastic layers were pulled snugly with more tension distally than proximally. Before wrapping in each turn, the elastic bandage was stretched approximately 2 and 1.5 inches at below and above tibial tuberosity level, respectively. The whole bandage attains a thickness of about two inches and extends above the ankle joint to six inches above the knee joint. Before applying this bandage, the sterile gauze pads were placed over the wound and followed by WebrilTM padding (Covidien, Mansfield, MA, US)
Non-compressive dressing is made by placing the sterile gauze pads over the wound and covering with the hypoallergenic self-adhesive, non-woven fabric tape.
Eligibility Criteria
You may qualify if:
- Patients who diagnosed primary osteoarthritis of knee and scheduled for primary unilateral total knee arthroplasty
- Patients aged more than 18 years
You may not qualify if:
- Patients who have a history of coagulopathy
- Patients who receive antiplatelet drug in the previous week
- Patients who treated other conditions with anticoagulant drug
- Patients who have previous history of thromboembolic event
- Patients who have vascular compromise of the operated limb
- Patients who have chronic kidney disease or liver cirrhosis
- Patients who refuse to participate the study
- Patients who have allergy to tranexamic acid, sulfa or morphine
- Patients who have blood loss per wound after surgery
- Patients who can not receive spinal anesthesia and peripheral nerve block
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chaturong Pornrattanamaneewong
Bangkok, 10700, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical instructor
Study Record Dates
First Submitted
February 28, 2016
First Posted
March 8, 2016
Study Start
March 1, 2016
Primary Completion
June 1, 2017
Study Completion
December 1, 2017
Last Updated
May 29, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share